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Abstract 
Objective: Parental psychiatric symptoms may negatively affect the outcome of children’s 
psychopathology. Studies have so far mainly showed a negative effect of maternal depression. We 
studied the associations between a broad range of psychiatric symptoms in mothers as well as fathers 
with child’s outcome. 
Method: Internalizing and externalizing psychiatric symptoms were assessed in 742 mothers, 440 
fathers and their 811 children at the first evaluation in three child and adolescent psychiatric outpatient 
clinics, and at follow-up (on average 1.7 years later). We tested predictions of child’s symptoms 
scores at follow-up by parental symptoms scores at baseline, as well as by parental scores at follow-up 
and the child’s score at baseline.  
Results: Children whose mother or father scored above the (sub)clinical threshold for psychiatric 
symptoms at baseline, had higher symptom scores at baseline and at follow-up. Offspring follow-up 
scores were most strongly predicted by offspring baseline scores, in addition to parental psychiatric 
symptoms at follow-up. Offspring symptom scores at follow-up were generally not predicted by 
parental scores at baseline. Mother and father associations were of similar magnitude.  
Conclusion: The higher symptom scores at follow-up in children of parents with psychopathology 
were mainly explained by higher symptom scores at baseline. The continuing parent-offspring 
associations may be a result of reciprocal effects, i.e., parental symptoms influencing offspring 
symptoms as well as of offspring symptoms influencing parental symptoms. Still, the results show that 
these children are at risk for persisting symptoms, possibly indicating the need to treat mothers’ and 
fathers’ psychopathology.   
Keywords: parental psychopathology, child psychopathology, parent-offspring associations, 
longitudinal 
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Introduction 
It has been repeatedly reported that parents whose children are assessed for a psychiatric disorder at a 
child and adolescent psychiatric outpatient clinic, have increased prevalence rates of psychiatric 
disorders, with estimates up to 68% (see1 for an overview of the literature). The next question then is 
how parental psychiatric symptoms are associated with the outcome of the children’s psychiatric 
symptoms.  
Multiple clinical studies have shown that parental depression before treatment is associated 
with poorer outcome in children treated not only for internalizing problems2-5 but also for 
externalizing problems6-9 including attention deficit hyperactivity disorder (ADHD).10,11 The 
association between parental anxiety before treatment and the outcome of offspring anxiety has also 
been investigated several times.5,12-19 A negative association was mostly observed.12-15  However, one 
longitudinal study did not find an association16 and some even reported a positive influence of parental 
anxiety on the outcome of anxiety in the child.17,18 Broader defined parental mental health, mainly 
internalizing symptomatology, was also associated to worse treatment outcome of youth total, 
internalizing, and externalizing problems20 and of youth outcomes regarding autism spectrum 
disorder,21 although no effect on the outcome for anxiety in youth has been observed as well.16  Far 
fewer studies investigated parental externalizing problems. Associations with worse outcome were 
reported between parental ADHD and youth ADHD22 and between father’s substance abuse and youth 
conduct problems.7 In addition, father’s ADHD appeared to be associated with a smaller decrease in 
children’s behavioral problems, but not ADHD.23  
Overall, previous studies have indicated that current parental symptoms at the start of 
treatment are negatively associated with the considered child’s outcomes, although for youth anxiety, 
findings are not entirely consistent. Still, there remain several outstanding issues. The overview above 
shows that the associations with parental externalizing symptoms are understudied, as well as 
associations between parent’s symptoms and offspring outcome across disorders i.e, the association 
between parental anxiety on for example offspring ADHD outcome. Moreover, father’s symptoms 
have been less extensively investigated. Several studies did not include fathers at all2,8,9,11,12,18,20, others 
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added the small samples of fathers to mother’s data.3,5-7,10,14,16,17,22 And in the studies that did analyze 
fathers separately, one asked mothers about fathers’ substance use7 and samples of fathers were still 
smaller and response rates were lower compared to mothers5,13,15,19,23 As fathers in a clinical 
population are as affected with psychopathology as mothers24 and their symptoms are evenly 
associated with offspring symptoms25 more focus on the effects on offspring outcome is warranted. 
In addition, if an association between parental symptoms before treatment and offspring 
outcome is found, the question is how to explain this association. Is the reported association between 
maternal depression and the outcome of offspring externalizing disorders, for example, due to 
maternal depression or is it better explained by co-morbid antisocial personality disorder in the 
mother? The latter can be investigated by also assessing other parental symptoms and analyzing them 
simultaneously. Another important issue is whether the observed association between parental 
symptoms at the start of the treatment and offspring outcome is due to a long-term effect of parental 
psychopathology at baseline or whether it is due to associations with parental symptoms at the time of 
the follow-up. The latter would mean that only concurrent parental and offspring symptoms are related 
to each other. This has been rarely addressed by earlier studies. Only one study14 included concurrent 
parent-offspring correlations for anxiety symptoms at baseline and follow-up and still reported an 
association with offspring outcome. 
The current naturalistic study aimed to address these issues. We analyzed data from 742 
mothers and 440 fathers and their 811 children who were all assessed on a broad range of internalizing 
and externalizing psychiatric symptoms at the time of the child’s assessment at a child and adolescent 
psychiatric outpatient clinic and at follow-up, on average 1.7 years later. Analyses were performed 
separately for mother’s and father’s data. The availability of parental and child’s measures at both time 
points allowed to investigate the association between parental psychiatric symptoms and child’s 
symptoms at baseline and at follow-up. Further, correlations within parental symptom scores, i.e., 
comorbidity, were taken into account.   
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Method 
Participants 
Data were obtained between April 2010 and December 2016 in three child and adolescent psychiatric 
outpatient clinics in The Netherlands (GGZ inGeest and UvA Minds in Amsterdam and the Erasmus 
University Medical Center-Sophia Children’s Hospital (EUMC) in Rotterdam) (see24 for a detailed 
description of the samples). Parents were asked to report on their own and their child’s psychiatric 
symptoms at the time of the first visit to the child and adolescent psychiatry outpatient clinics. Parents 
who were not sufficiently fluent in Dutch were excluded from participation. Families were approached 
between one to five years later, on average 1.7 years, to complete the same survey assessing their 
child’s and their own psychiatric symptoms. From the 1,771 families with surveys available at 
baseline, follow-up data were received from 811 families (N girls 303, N boys 508, N mothers 742, N 
fathers 440) (a family-response rate of 45.8%). Girls were on average 11.9 years (SD = 3.5) at baseline 
and 13.9 years (SD = 3.5) at follow-up. Boys were on average 10.9 years (SD = 3.0) at baseline and 
12.47 years (SD = 3.1) at follow-up. The mothers, fathers and children of the families that did not 
participate in the follow-up measurement showed similar psychiatric symptom scores at baseline 
compared to the mothers, fathers and children of the families who did participate in the follow-up 
(Table S1, available online).  
Demographic characteristics of the mothers and fathers of the included families are shown in 
Table 1. Table S2, available online, shows the demographic characteristics, length of follow-up and 
response rate for the three different clinics. At UvA Minds, it was part of the clinical practice that 
parents were asked to report on their own and their child’s psychiatric symptoms immediately after the 
child received treatment, which was on average after one year. The families from GGZ inGeest and 
EUMC were approached as part of this research project. The time of the follow-up differs between 
GGZ inGeest and EUMC, as the data at baseline were collected earlier in EUMC. This different 
approach probably explains the lower response rate in GGZ inGeest en EUMC. Despite the 
differences in follow-up time, mean scores at baseline and follow-up did not systematically differ 
between the different psychiatric outpatient clinics (Table S2, available online). 
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 As this is a naturalistic follow-up study, children as well as parents received treatment as the 
clinicians and families deemed appropriate. Treatment for children could include parental guidance, 
cognitive behavioral treatment, mindfulness and medication. Parents could be directed for individual 
treatment.  
Measures 
Demographic information regarding the child’s age, gender and the parents’ education level, 
employment and relationship status were collected in the baseline survey.  
Psychiatric symptoms in children and parents were measured with the age-appropriate version 
of questionnaires belonging to the Achenbach System of Empirically Based Assessment (ASEBA) i.e., 
the Child Behavior Checklist (CBCL,27) and the Adult Self Report (ASR,28). In both questionnaires, 
emotional and behavior problems are rated on a three-point scale (not true, somewhat true, very true). 
The CBCL depressive, anxiety, attention deficit/hyperactivity (ADHD), oppositional-defiant and 
conduct problems and the ASR depressive, anxiety, avoidant personality, ADHD, and antisocial 
personality problems DSM-oriented scales were analyzed, as these scales are more congruent with the 
terminology used in clinical practice, compared to the empirical scales that can also be calculated. 
Good validity has been reported.27,28 The ASR manual provides cut-off scores for “subclinical” and 
“clinical” scores for each sex indicating whether an individual may have clinically relevant symptoms. 
The cut-offs for the subclinical and clinical scores reflect the 93rd and 97th percentile in men and 
women of the general population. 
Analyses 
We calculated untransformed mean mother’s, father’s, and child psychiatric symptom scores at 
baseline and follow-up using SPSS (version 24). We performed t-tests to compare the scores between 
children whose parents scored below and above the (sub)clinical threshold at baseline. Next, we 
calculated an effect size (Cohen’s d) for the mean difference in the child’s psychiatric symptom scores 
at baseline and follow-up for the two groups of children. As psychiatric symptoms in a parent can 
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influence the ratings of their child’s psychiatric symptoms,29 we repeated these analyses with the 
ratings of the other parent of the child’s psychiatric problems.  
We used Mplus to analyse for each of the five DSM oriented scales measured in the child the 
structural equation model depicted in Figure 1. To make optimal use of the parental data available, the 
predictions were analyzed for the mother and father ratings separately, i.e., besides the other variables 
in the model, the child’s depression rated by mother was predicted by the mother’s own scores on the 
ASR DSM oriented scales and the child’s depression rated by father was predicted by the father’s own 
scores on the ASR DSM oriented scales (β11s in Figure 1). This leaves a total of ten models that were 
tested, five for the mother’s ratings and five for the father’s ratings. In each model, the child’s 
psychiatric symptom score at follow-up was predicted by the parental psychiatric symptom scores at 
baseline (β12s in Figure 1) and follow-up (β22s in Figure 1), and the child’s psychiatric symptom 
score at baseline.) An earlier study has already shown that parental and offspring psychiatric 
symptoms at baseline are also associated.1 Therefore, predictions of the child’s scores at baseline by 
the parental scores at baseline were also included in the model (β11s in Figure 1). Overall, the model 
comprised concurrent associations between parent and offspring symptom scores at baseline and 
follow-up, as well as longitudinal associations between parental symptom scores at baseline and 
offspring scores at follow-up.   
Linear regression analyses were performed in Mplus to decide which demographic variables 
needed to be added as covariates in the model. These analyses showed that parental education level, 
employment, and relationship status were not associated with offspring symptoms at follow-up, thus 
were not added. Gender and age of the child, and time of follow-up were added to the model. The 
older the child, the worse the child’s depressive, anxiety and conduct problems at follow-up 
(coefficients ranged between .08 and .12, p<.05) and the more time between baseline and follow-up 
the higher the child’s depressive, anxiety, ADHD and conduct problems (coefficients ranged between 
.31 and .32, p<.05).  
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Because of the differences in response rates and the length of follow-up time between the 
clinics, we checked whether this could have affected the results. We repeated all the analyses above 
for the three clinics separately and then tested whether the beta’s were significantly different between 
GGZ inGeest and UvA Minds, between GGZ inGeest and Erasmus and between Uva Minds and 
Erasmus. None of these tests showed significant differences (Table S3, available online, for the test 
statistics).  
We performed two sensitivity analyses. Since the ratings of the child may be influenced by the 
parent’s psychopathology, we also report the child’s symptoms as rated by the other parent, i.e., the 
child’s depression rated by father by the mother’s ASR scores at baseline and follow-up (Table S4, 
available online). Furthermore, as mother’s and father’s scores are also correlated, a model 
incorporating the effects of both mothers and fathers simultaneously would have been preferable.30 
This would, however, have led to a smaller sample size for the mother ratings as fewer fathers 
participated and complete data is a necessity for predictors in a regression model. We performed the 
five analyses including all mother’s and father’s psychiatric symptoms at baseline and follow-up 
simultaneously as predictors (n= 334 families) to investigate whether associations were not better 
explained by an association with the symptoms of the other parent (Table S5, available online).  
In our main analyses we tested 11 correlated predictors (the parental psychiatric symptom 
scores at baseline and follow-up and the child’s symptom score at baseline) and therefore used a p 
value of 0.007, calculated by the software ‘matSpD’,31 as the threshold for statistical significance. 
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Results 
Parental and offspring symptom scores at baseline and follow-up 
For each psychiatric symptom scale, there is, on average, a decrease in the parental mean scores over 
time (p<.001, with an average effect size of .28). 
Table 2 shows the offspring mean scores at baseline and follow-up for the children whose 
father or mother scored in the normal range for all DSM oriented scales and for the children whose 
parent scored above the (sub)clinical threshold at baseline (35.6% of mothers and 33% of fathers for at 
least one of the scales). Table S6, available online, shows the scores for the children whose parent 
scores above the (sub)clinical threshold per parental psychiatric symptom score. In general, offspring 
symptom scores were significantly higher if the parent scored above threshold. At baseline, this was 
seen for the majority of the offspring symptom scores, regardless of the considered parental scale. This 
is in line with earlier univariate analyses in a subsample of the current population.1 At follow-up, 
offspring symptom scores were mostly only higher for the scales that measured similar symptoms as 
the scale for which the parent scored above threshold at baseline (Table S6, available online). Since 
parental psychopathology can influence the parental perception of their child’s psychopathology, mean 
scores were also calculated for the ratings performed by the other parent. This revealed a similar 
pattern, although the differences between offspring whose parents scored within the normal and in the 
(sub)clinical range were smaller (Table S4, available online). It also becomes clear from Table S6, 
available online, that in both groups of children, i.e., children with parents with psychopathology and 
children with parents without psychopathology, the symptom scores at follow-up were, on average, 
lower. Both groups showed similar relative improvement, as reflected by the effect sizes (d) (Table S7, 
available online) that varied between .46 and .71 for children with parents with psychopathology and 
between .30 and .54 for the children with parents without.  
Predictions of child’s scores at follow-up 
Table 3 shows the standardized regression coefficients for each predictor, indicating the effect size, 
i.e., how many standard deviations the child’s symptoms score will increase, as estimated in the model 
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shown in Figure 1. The child’s psychiatric symptom scores at follow-up were most strongly predicted 
by the child’s psychiatric symptom scores at baseline (coefficients ranged between .37 and .68).  
Further, several parental symptom scores were significantly associated with concurrently 
measured offspring symptom scores, i.e., parental and offspring scores measured at baseline were 
associated (coefficients β11s in Figure 1) as well as parental and offspring scores measured at follow-
up (coefficients β22s in Figure 1). At baseline, similar to the results of earlier analyses,1 mother’s 
anxiety symptoms predicted offspring anxiety, oppositional-defiant and conduct problems 
(coefficients ranged between .19 and .36), and father’s anxiety problems predicted depressive, anxiety 
and oppositional-defiant problems in the child and father’s ADHD predicted ADHD symptoms 
(coefficients ranged between .21 and .41). At follow-up, mother’s anxiety symptoms predicted 
offspring depressive, anxiety and ADHD and mother’s ADHD problems predicted offspring anxiety, 
ADHD and conduct problems (coefficients ranged between .10 and .19). Father’s antisocial 
personality problems at follow-up predicted oppositional-defiant and conduct problems in the child at 
follow-up (coefficients were .17 and .27). There were fewer significant predictions at follow-up by 
father’s symptoms scores than by mother’s scores. This can be explained by the smaller sample size of 
fathers at follow-up, as the coefficients for father’s psychiatric symptoms were mostly of similar 
magnitude as the coefficients for the mother’s psychiatric symptoms.  
Parental symptom scores at baseline did not predict offspring scores at follow-up, with the 
exception of mother’s ADHD predicting lower ADHD scores in the child (coefficient -.12).  
The results of the analyses including mother’s and father’s psychiatric symptom scores 
simultaneously were similar, although fewer parent-offspring associations were significant probably 
because of the smaller sample size (Table S5, available online) and no parental psychiatric symptoms 
at baseline predicted the child’s outcomes. The standardized regression coefficients for the different 
regression analyses are given in Table S5, available online, (coefficients ranged between .25 and .35 at 
baseline and between .17 and .29 at follow-up). These results indicate that the associations found in 
the former analyses were not explained by resemblance between parents. 
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Discussion 
We examined, in a clinical sample, the associations between mother’s and father’s psychiatric 
symptoms with the outcome of the child’s psychiatric symptoms. Firstly, the analyses of the mean 
symptom scores indicate that children referred to psychiatric outpatient clinics whose mothers or 
fathers scored in the (sub)clinical range at baseline (around 34% of the parents), have higher symptom 
scores at baseline and at follow-up than children whose parents scored in the normal range for each 
scale, although the differences were smaller at follow-up (Table 2). The relative improvement between 
baseline and follow-up, as expressed in effect size d, was not smaller in children whose parents scored 
above threshold compared to children whose parents scored in the normal range (Table S7, available 
online). But given their higher scores at baseline, they should have improved even more, to reach the 
same level as children whose parents score in the normal range. Secondly, our model (Figure 1) 
showed that child’s outcome was not associated with parental psychiatric symptom scores at baseline. 
The only longitudinal significant prediction from parental symptoms to offspring outcome was higher 
mother’s ADHD symptoms at baseline predicting lower ADHD scores in their children at follow-up, 
but the effect was small. Instead, the child’s follow-up scores were for the largest part predicted by the 
child’s symptom score at baseline, in addition to predictions by concurrently measured parental 
psychiatric symptoms at follow-up, mainly mother’s and father’s anxiety or ADHD.  
All in all, our results indicate that referred children with parents with psychopathology have a 
poorer outcome than referred children with parents without psychopathology. This is mostly explained 
by the more severe symptoms at baseline and by associations between parental and children’s 
symptoms both measured at follow-up. Notably, the associations with mother’s and father’s symptom 
scores were of similar magnitude for mothers and fathers, indicating that fathers (improvement in) 
psychopathology is as important for child’s outcome than mothers’. This is in line with the heritability 
of psychiatric symptoms at childhood32 and with theories predicting an important role for fathers in 
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children overcoming psychopathology.33 The concurrent parent-offspring associations were less strong 
at follow-up than at baseline, but this is probably explained by the strong predictions of the child’s 
baseline symptoms on the child’s score at follow-up. Future studies should provide further insight into 
the association between parental ADHD and offspring ADHD over time before it is possible to draw 
any conclusions about this isolated finding.  
Our findings may seem in contrast with the previous studies suggesting that poorer outcome in 
children is associated with parental symptoms at baseline. However, all these studies,2-8,10-13,15-19-23,but 
two,9,14 did not take into account the associations between parental and children’s scores at follow-up. 
This may explain the discrepancies. One of the two studies that also included an association between 
parental psychopathology at follow-up with child’s scores at follow-up, reported an association 
between mother’s anxiety at baseline and higher scores at follow-up in mother-reported child anxiety, 
but not in clinician-rated child anxiety.14 The other study used a different method to investigate the 
mother’s symptoms at follow-up. They tested the difference in children’s externalizing symptoms at 
follow-up between children whose mothers were not depressed, whose mothers were only depressed at 
baseline and whose mothers were depressed at baseline and follow-up.9 The children in the latter 
group showed the highest scores, in line with the concurrent associations at follow-up in our model.   
Baseline child’s symptoms were also not always incorporated in a similar way as in the 
current study. Sometimes, a child’s change score was analyzed as outcome measure6,10,22,34 or whether 
or not remission of a diagnosis was achieved.5,13 These analyses did not account for the higher 
symptom scores at baseline in children whose parents have psychopathology. A quantitative measure 
of the child’s psychiatric symptoms at baseline and follow-up provides the most precise information 
that should be incorporated in an analysis investigating which variables are further associated with a 
child’s outcome.   
 Parent-offspring associations for psychopathology may be influenced by spousal resemblance 
for psychiatric symptoms.30 A study on the association between mother’s depression and childhood 
conduct problems, for example, showed that this association was partly explained by father’s 
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antisocial personality problems.35 However, our additional analyses including the mother’s and 
father’s symptoms simultaneously in the model showed that spousal resemblance for psychiatric 
symptoms did not explain the effects as found in the separate analyses. 
The results should be considered in view of several limitations. First, to analyze the largest 
possible sample, we used the report on the child’s psychopathology of the parent that also reported on 
his or her own symptoms. Psychiatric symptoms in the parent, however, can influence the ratings of 
their child’s psychiatric symptoms.29 Table S4, available online, showed that similar differences were 
seen in offspring symptom scores depending on the other parent scoring below or above the 
(sub)clinical thresholds, although the differences were smaller (average effeas ct size of .26 compared 
to an average effect size of .36). Second, although the sample size was large, around 50% of the 
families were lost to follow-up. Comparison of mothers, fathers and child’s symptoms scores at 
baseline showed no differences between families who did or did not participate at follow-up (Table 
S1, available online). This suggests that participation is not associated to mother’s, father’s or 
offspring psychopathology at baseline. It is still possible that symptoms at follow-up, either of the 
parents or children, were associated with drop-out.  
 Our results do not imply anything about the direction of effect. Parents and children could also 
be exposed to similar adverse events, such as parental unemployment, influencing both parental and 
offspring psychopathology. Further, it is clear from other studies that parental and offspring symptoms 
mutually influence each other. It has, for example, been found that a decrease in offspring anxiety 
symptoms is related to a decrease in mother’s anxiety symptoms14,26 and offspring psychopathology 
improves when mothers are successfully treated for depression.36,37  
Still, findings from the present naturalistic study may have important clinical implications. 
They show that children of parents with psychopathology, which was around 30% of children in this 
sample,24 are at risk for continuing higher levels of psychiatric symptoms on the longer term. Relative 
improvement is not smaller compared to children whose parents score in the normal range, but should 
be even larger for them to function within the normal range because of the higher scores at baseline. 
Together with our previous findings of higher spousal resemblance for psychopathology in a clinical 
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sample and the association between unemployment and parents not being together with parental 
psychopathology, it is clear that in part of the families assessed in child and adolescent psychiatric 
clinics, there is an accumulation of risk factors that make these families particularly vulnerable. Even 
in the studies showing improvement in untreated family members after treatment of the proband, the 
proportion of mothers or children with psychopathology is still high (17.7% of the mothers2 and ~20% 
of children37 at follow-up. It is timely that treatment programs specifically targeted at these high-risk 
families with multiple affected members are developed and investigated. Given the continuing 
associations between parental and offspring psychopathology, both in mothers and fathers, adding 
treatment for the parental symptoms to the treatment of the child warrants further research.   
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Figure 1. This Model was Used Separately for the Five Different Psychiatric Symptom Scores 
in the Child (eg, Depressive, Anxiety, Attention-Deficit/Hyperactivity Disorder [ADHD], 
Oppositional Defiant Disorder [ODD] and Conduct Problems) Rated by the Mother or by the 
Father). 
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Table 1. Demographic Characteristics and Psychiatric Symptom Scores of the Parents at 
Baseline and Follow-Up 
 Mothers (N=742)  Fathers (N=440) 
Mean age (SD) at baseline 
Mean age (SD) at follow-up 
44.4(6.1) 
46.1(5.9) 
 47.0(6.2) 
48.5(6.5) 
 
Education level (n(%)) 
   
     Low 71(9.8%)  42(10.2%) 
    Intermediate 190(26.1%)  90(21.8%) 
    High 467(64.1%)  281(68%) 
Employment status    
    Yes 604(82.2%)  391(92.2%) 
    No 131(17.8%)  33(7.8%) 
Relationship status    
    Yes 507(68.7%)  359(82%) 
    No 231(31.3%)  79 (18%) 
Note: Education level: low (primary school, lower vocational schooling and lower 
secondary schooling), middle (intermediate vocational schooling and intermediate/higher 
secondary schooling), high (higher vocational schooling, university and post graduate). 
Parents were employed or unemployed (yes/no). Relationship status: together with the 
biological parent (yes/no). ADHD = attention deficit/hyperactivity disorder. 
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Table 2. Means (SDs) of the Child’s Psychiatric Symptom Scores at Baseline and Follow-Up, Rated by Mothers (A) or by Fathers (B) for 
Children of Parents Whose Mother’s (A) or Father’s (B) Psychiatric Symptom Score was in the Normal or (Sub)Clinical Range at Baseline. 
    
 
Parental score 
normal on all scales 
Parental score 
(sub)clinical at baseline 
 
A 
Mother 
Child baseline: 
 
 
         N=460 
 
 
               N=258 
Depressive 5.02(3.88) 7.00(4.25) 
Anxiety  3.57(2.76) 4.23(2.83) 
ADHD 6.01(3.51) 7.38(3.57) 
ODD 3.54(2.64) 4.52(2.56) 
Conduct 3.10(3.27) 4.33(4.14) 
   
Child follow-up: N=464 N=248 
Depressive 3.07(3.56) 4.21(3.54) 
Anxiety 2.16(2.44) 2.76(2.52) 
ADHD 4.73(3.30) 5.65(3.49) 
ODD 2.29(2.28) 2.73(2.29) 
Conduct 1.99(2.88) 2.59(3.29) 
   
B   
Father 
Child baseline: 
N=348 N=188 
Depressive 4.01(3.711) 6.16(4.02) 
Anxiety 2.87(2.43) 4.07(2.62) 
ADHD 5.49(3.26) 7.19(3.32) 
ODD 3.03(2.52) 4.30(2.42) 
Conduct 2.80(3.20) 4.42(3.80) 
   
Child follow-up: N=275 N=138 
Depressive 2.91(3.57) 3.62(3.08) 
Anxiety 1.95(2.30) 2.52(2.22) 
ADHD 4.16(3.21) 5.67(3.34) 
ODD 2.08(2.16) 3.07(2.34) 
Conduct 1.73(2.54) 2.69(2.96) 
Note: ADHD = attention deficit/hyperactivity disorder; ODD = oppositional defiant disorder. 
*p<.05; **p<.01; ***p<.001  
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Table 3. Standardized Regression Coefficients (Standard Errors [SEs]) Obtained in the Model (Figure 1) in Which the Child’s Psychiatric 
Symptom Score at Follow-Up was Predicted by the Child’s Psychiatric Symptom Score at Baseline (Timepoint 1 [T1]), the Parental Psychiatric 
Symptoms at Baseline (β12s) and the Parental Psychiatric Symptoms at Follow-Up (β22s). 
 Child psychiatric problems outcome  
 Depressive Anxiety ADHD Oppositional-defiant Conduct 
 
β11 β12 β22 β11 β12 β22 β11 β12 β22 β11 β12 β22 β11 β12 β22 
Mothers                
T1 Child  .44§ (.03)   .37§ (.03)   .60§ (.03)   .54§ (.03)   .48§ (.03)   
                
Depressive .11( .06) -.06(.06) 
-.09(.07) 
.05(.08) 
-.06(.05) 
-.03(.06) 
 
 
 
 
-.07(.07) 
-.13(.09) 
-.11(.09) 
-.11(.07) 
.09(.08) 
.10(.06) -.07(.05) -.05(.04)  
.08(.05) 
-.01(.05) 
-.07(.03) 
-.03(.04) 
 
 
 
 
-.12(.05) 
-.02(.06) 
-.02(.06) 
-.01(.04) 
.04 (.05) 
-.03(.04) .07(.06) -.02(.05) 
-.03(.06) 
-.08(.07) 
-.12§ (.04) 
.01(.05) 
 
 
 
 
.05(.06) 
-.10(.08) 
-.13(.08) 
-.07(.05) 
-.01(.06) 
.00(.05) .01(.04) -.02(.03) 
-.11(.05) 
-.03(.05) 
-.06(.03) 
.05(.04) 
 
 
 
 
.04(.04) 
-.04(.06) 
-.10(.06) 
.01(.04) 
-.05(.05) 
.05(.04) -.05(.06) -.08(.05) 
.02(.06) 
-.13(.06) 
-.05(.04) 
.04(.05) 
 
 
 
 
.01(.05) 
.05(.07) 
-.09(.07) 
-.05(.05) 
-.09(.06) 
-.02(.05) 
Anxiety .22(.08) .20§ (.07) .36§ (.06) .19§ (.03) -.02(.08) .18§ (.04) .19§ (.06) .08(.05) .25§ (.08) .14(.06) 
Avoidant .07(.08) .06(.08) .07(.06) .11(.06) .01(.08) .09(.07) -.03(.06) .01(.05) -.08(.08) .12(.07) 
ADHD .01(.05) .09(.05) -.01(.03) .10§ (.03) .11(.04) .19§ (.04) .01(.03) .05(.03) .01(.04) .13§ (.04) 
Antisocial .16(.07) .08(.08) .04(.05) .06(.05) .05(.07) .05(.07) .14(.05) .11(.05) .18(.07) .07(.07) 
 
          
Fathers           
T1 Child  .44§ (.04)  .48§ (.04)  .68§ (.04)  .55§ (.04)  .51§ (.03)  
           
Depressive .07(.09) .16(.08) -.11(.06) .14(.06) -.02(.08) .00(.07) -.04(.06) -.04(.05) .04(.07) -.06(.06) 
Anxiety .41§ (.11) .23(.10) .38§ (.07) .11(.07) .23(.10) .16(.08) .21§ (.07) .16(.06) .16(.09) .16(.07) 
Avoidant .02(.11) .22(.10) .08(.07) .05(.07) -.14(.09) .15(.08) -.04(.07) -.06(.06) -.18(.09) .01(.07) 
ADHD .13(.07) .03(.07) .10(.04) -.01(.05) .25§ (.06) .14(.06) .06(.05) .01(.04) .12(.06) .03(.05) 
Antisocial -.03(.09) .02(.07) -.03(.06) .02(.05) .02(.07) .08(.06) .13(.06) .17§ (.05) .14(.07) .27§ (.06) 
Note: The child’s psychiatric symptom score at baseline was also predicted by all parental psychiatric symptom scores at baseline (β11s). ADHD 
= attention deficit/hyperactivity disorders. 
§p< 0.007.  
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Supplementary material 
Table S1. Means and SDs of the Maternal and Paternal Psychiatric Symptoms Scores 
of the Adult Self Report (ASR) and of Their Child’s Psychiatric Scores of the Child 
Behavior Checklist (CBCL) at Baseline Depending on Whether or not Parents 
Participated in the Follow-Up. 
 Mothers  Fathers 
 Baseline without 
follow-up 
Baseline score with 
follow-up 
  Baseline without 
follow-up 
Baseline score 
with follow-up 
ASR       
Depressive 5.03 (4.57) 4.70 (4.03)   3.29 (3.35) 3.30 (3.37) 
Anxiety 4.30 (2.92) 4.12 (2.54)   3.18 (2.47) 3.18 (2.36) 
Avoidant 2.49 (2.49) 2.40 (2.33)   2.13 (2.31) 2.38 (2.42) 
ADHD 5.38 (4.38) 5.24 (4.29)   4.69 (4.02) 5.16 (4.11)* 
Antisocial 2.43 (2.56) 2.45 (2.45)   2.93 (2.74) 3.11 (2.86) 
CBCL       
Depressive 6.03 (4.29) 5.76 (4.16)   4.62 (3.81) 4.77 (3.94) 
Anxiety 4.02 (2.83) 3.79 (2.81)   3.33 (2.57) 3.29 (2.56) 
ADHD 6.36 (3.63) 6.50 (3.60)   5.54 (3.46) 6.05 (3.37)* 
ODD 3.93 (2.65) 3.88 (2.65)   3.51 (2.54) 3.47 (2.55) 
Conduct 3.76 (3.78) 3.58 (3.73)   3.17 (3.39) 3.36 (3.49) 
Note: ADHD = attention deficit/hyperactivity disorder; ODD = oppositional defiant 
disorder. 
*p< .05 
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Table S2. Demographic Characteristics and Psychiatric Symptom Scores of the Parents at Baseline and Follow-Up per Clinic 
 Mothers  Fathers  
 UvA Minds GGZ ingeest Erasmus  Uva Minds GGZ ingeest Erasmus 
Family response rate 60.6%  34.06%  31.4%   60.6%  34.06%  31.4%  
Mean age (SD) at baseline 
Time between  
baseline and follow-up 
45.32 (5.63) 
1.06 (.55) 
 
43.97 (6.59) 
1.9 (.49) 
39.67 (6.11) 
4.63 (.47) 
 47.57 (5.91) 
1.06 (.64) 
48.86 (7.28) 
1.85 (.55) 
42.54 (5.21) 
4.73 (.55) 
 
Education level (n(%)) 
       
     Low 38 (6.8%) 14 (12.5%) 26 (22.8%)  55 (12.1%) 9 (11.4%) 23 (23%) 
    Intermediate 127 (22.6%) 30 (26.8%) 44 (38.6%)  97 (21.4%) 18 (22.8%) 36 (36%) 
    High 396 (70.6%) 68 (60.7%) 44 (38.6%)  302 (66.5%) 52 (65.8%) 41 (41%) 
Employment status        
    Yes 465 (81.6%) 91 (81.3%) 104 (91.2%)  426 (91%) 68 (85%) 96 (94.1%) 
    No 105 (18.4%) 21 (18.8%) 10 (8.8%)  42 (9%) 12 (15%) 6 (5.9%0 
Relationship status        
    Yes 358 (67.7%) 71 (65.1%) 78 (78%)  271 (81.4%) 38 (86.4%) 43 (86%) 
    No 171 (32.3%) 38 (34.9%0 22 (22%)  62 (18.6%) 6 (13.6%) 7 (14%) 
        
 Baseline Follow-up Baseline Follow-up Baseline Follow-up  Baseline Follow-up Baseline Follow-up Baseline Follow-up 
Depressive 4.74 
(4.02) 
3.62  
(3.59) 
5.31  
(4.97) 
4.68*  
(4.74) 
4.74 
(4.30) 
3.75  
(3.95) 
 3.33  
(3.36) 
2.70  
(3.29) 
3.13  
(3.29) 
2.95 
(3.27) 
3.35  
(3.43) 
2.24 
(2.38) 
Anxiety 4.16  
(2.64) 
3.27  
(2.56) 
4.40 
(3.10) 
3.70  
(3.07) 
4.16 
(2.60) 
3.42 
(2.52) 
 3.14  
(2.41) 
2.36 
(2.35) 
3.07  
(2.28) 
2.53 
(2.01) 
3.35  
(2.54) 
2.55 
(2.23) 
Avoidant 2.23  
(2.24) 
1.81  
(2.11) 
2.52  
(2.64) 
2.34  
(2.68) 
2.92 
(2.53) 
2.43** 
(2.37) 
 2.33  
(2.39) 
1.88 
(2.24) 
1.94 
(2.27) 
1.93* 
(2.22) 
2.35  
(2.38) 
2.10 
(2.17) 
ADHD 5.52  
(4.47) 
4.39 
 (3.94) 
5.11 
(4.25) 
4.64 
 (4.15) 
5.02 
(4.07) 
3.93 
(3.69) 
 5.26  
(4.14) 
4.22 
(3.82) 
4.23  
(4.10) 
4.35** 
(3.46) 
4.68 
(3.76) 
3.08* 
(2.52) 
Antisocial 2.52  
(2.63) 
1.77  
(1.95) 
2.54 
(2.61) 
1.66  
(2.07) 
2.11 
(2.01) 
1.07** 
(1.58) 
 3.21  
(2.86) 
2.60 
(2.91) 
3.13 
(3.11) 
2.15 
(2.73) 
2.44 
(2.26) 
1.43** 
(1.60) 
Note: ADHD = attention-deficit/hyperactivity disorder 
* p< 0.05 compared to UvA Minds sample; ** p< 0.01   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table S3. The Log-Likelihood (-2LL) for the Models With Separate Beta’s per Clinic (Free) and With the Beta’s Constrained to be Equal 
Between Either the GGZ inGeest and the Erasmus Sample, the GGZ ingest and the Uva Minds Sample, and the Erasmus and Uva Minds sample.   
GGZ inGeest - Erasmus GGZ inGeest - Uva Minds Erasmus- Uva Minds 
-2LL diff -2LL p -2LL diff -2LL p -2LL diff -2LL p 
Free (49) Equal (28) Free (49) Equal (28) Free (49) Equal (28) 
Mothers 
Depressive 925,386 933,072 -7,686 .99 3097,505 3105,206 -7,701 .99 3116,092 3129,172 -13,08 .91 
Anxiety 817,642 828,261 -10,619 .97 2676,71 2687,614 -10,904 .96 2733,391 2753,428 -20,037 .52 
ADHD 882,815 892,971 -10,156 .98 2950,656 2962,954 -12,298 .93 3000,155 3013,467 -13,312 .89 
ODD 733,594 746 -12,406 .93 2624,706 2642,277 -17,571 .68 2601,387 2618,656 -17,269 .69 
Conduct 905,907 916,956 -11,049 .96 2939,536 2950,533 -10,997 .96 2979,786 2995,974 -16,188 .76 
 
Fathers  
Depressive 386,044 412,755 -26,711 .18 1823,787 1839,052 -15,265 .81 1838,172 1867,247 -29,075 .11 
Anxiety 313,361 336,411 -23,05 .34 1550,682 1561,687 -11,005 .96 1565,339 1590,702 -25,363 .23 
ADHD 381,682 393,039 -11,357 .96 1705,056 1717,036 -11,98 .94 1745,432 1763,761 -18,329 .63 
ODD 296,357 319,633 -23,276 .33 1529,121 1540,765 -11,644 .95 1520,544 1533,775 -13,231 .90 
Conduct 340,725 355,231 -14,506 .85 1666,252 1687,714 -21,462 .43 1678,948 1696,398 -17,45 .68 
 
Note: Significance testing was based on the likelihood ratio test, where the negative log-likelihood (-2LL) of the constrained model is subtracted 
from the -2LL of the free model with a degrees of freedom of 21 (49-28). ADHD = attention-deficit/hyperactivity disorder; ODD = oppositional 
defiant disorder  
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Table S4. Means (SDs) of the Child’s Psychiatric Symptom Scores at Baseline and Follow-Up for Children of Parents Whose Mother’s (A) or 
Father’s (B) Psychiatric Symptom Score was in the Normal or (Sub)Clinical Range at Baseline.  
 Parental score 
normal on all scales 
Parental score (sub)clinical at baseline 
Depressive Anxiety Avoidant  ADHD Antisocial 
A 
Mother score - Child 
score father rated 
Child baseline: 
 
N=339 
 
N= 68 
 
N = 31 
 
N = 29 
 
N = 72 
 
N = 42 
Depressive 4.38 (3.96) 6.29 (4.17)*** 6.48 (4.88) ** 6.38 (3.00) ** 5.06 (3.65) 5.60 (4.59) 
Anxiety 3.18 (2.61) 3.72 (2.44) 4.36 (2.69) * 4.44 (2.57) * 2.91 (2.14) 3.31 (2.82) 
ADHD 5.91 (3.29) 6.31 (3.35) 5.81 (3.68) 6.14 (3.58) 6.65 (3.79) 6.31 (3.35) 
ODD 3.33 (2.55) 3.78 (2.44) 3.06 (2.29) 3.93 (2.05) 3.50 (2.79) 4.07 (2.44) 
Conduct 3.09 (3.49) 3.93 (3.38) 3.26 (3.07) 3.31 (3.13) 4.17 (4.17)* 3.91 (3.50) 
       
Child follow-up: N= 278 N = 45 N = 24 N = 25 N = 51 N = 36 
Depressive 2.92 (3.54) 3.89 (3.54) 2.95 (3.37) 4.00 (2.80) 3.65 (3.33) 3.86 (3.68) 
Anxiety 2.02 (2.21) 2.38 (2.10) 2.33 (2.01) 3.08 (2.81) * 2.20 (2.33) 2.97 (2.62) * 
ADHD 4.42 (3.38) 5.39 (3.03) 4.33 (3.21) 5.32 (3.22) 5.33 (3.19) 5.64 (3.21) * 
ODD 2.27 (2.19) 2.84 (2.44) 1.75 (1.78) 3.28 (2.48) * 2.61 (2.47) 3.25 (2.88) * 
Conduct 1.90 (2.59) 2.49 (3.27) 1.67 (1.74) 3.20 (3.86) * 2.88 (3.40)* 2.69 (3.40) 
B 
Father score – Child      
score mother rated                                              
Child baseline: 
 
                     
  
                  N=390 
 
 
 
N=71 
 
 
 
N=35 
 
 
 
N=67 
 
 
 
N=73 
 
 
 
N=47 
Depressive 5.32 (3.97) 6.56 (3.88)* 7.37 (3.87)** 6.43 (4.24) * 6.33 (3.67) * 6.38 (4.11) 
Anxiety 3.76 (2.82) 3.92 (2.58) 4.43 (2.69) 4.11 (2.83) 3.84 (2.66) 3.66 (2.48) 
ADHD 6.39 (3.66) 7.04 (3.59) 7.02 (3.06) 6.30 (3.38) 7.48 (3.46) * 7.26 (3.48) 
ODD 3.75 (2.70) 4.32 (2.55) 4.26 (2.42) 3.73 (2.19) 4.14 (2.62) 4.77 (2.41) * 
Conduct 3.44 (3.85) 3.73 (3.28) 3.11 (2.18) 3.15 (3.43) 3.73 (3.73) 4.81 (3.55) * 
       
Child follow-up: N=393 N = 70 N = 35 N = 63 N = 73 N = 45  
Depressive 3.24 (3.66) 4.03 (3.31) 3.66 (3.11) 3.40 (3.19) 3.53 (3.19) 4.76 (3.43) ** 
Anxiety 2.22 (2.42) 2.73 (2.43) 2.43 (1.85) 2.25 (2.19) 2.55 (2.26) 2.60 (2.23) 
ADHD 4.77 (3.36) 6.33 (3.44) *** 5.26 (2.90) 4.98 (3.30)  6.51 (3.75) *** 6.47 (3.07)*** 
ODD 2.33 (2.33) 2.93 (2.45) * 2.66 (2.17) 2.30 (1.97) 2.71 (2.27) 3.58 (2.38)*** 
Conduct 2.04 (2.94) 2.41 (2.98) 1.71 (2.61) 2.03 (3.29) 2.36 (3.58) 3.40 (3.92)** 
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Note: The difference with Table S7 is that the offspring symptoms are assessed by the other parent. ADHD: Attention deficit/hyperactivity 
disorder. ODD: Oppositional defiant disorder. 
* p<.05; ** p<.01; *** p<.001 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table S5. Standardized Regression Coefficients Standard Error (SE) of the Analyses Including Both the Maternal and Paternal Psychiatric 
Symptoms Simultaneously (N=334 Families).  
 Child psychiatric problems outcome  
 Depressive Anxiety ADHD Oppositional-defiant Conduct 
 
β11 β12 β22 β11 β12 β22 β11 β12 β22 β11 β12 β22 β11 β12 β22 
Child at baseline 
.39§ (.05)   .32§ (.04)   .55§(.04)   .52§ (.04)   .43§ (.04)   
Mothers                
Depressive .16 (.09) -.17 (.08) 
-.17 (.11) 
.06 (.11) 
.00 (.08) 
-.10 (.09) 
 
 
.09 (.09) 
-.15 (.11) 
-.12 (.11) 
-.01 (.08) 
.10 (.09) 
.10 (.08) .05 (.07) -.10 (.05) 
.01 (.08) 
.06 (.07) 
-.05 (.05) 
-.07 (.06) 
 
 
.01 (.06) 
-.08 (.08) 
.01 (.07) 
-.01 (.05) 
.06 (.06) 
-.06 (.06) -.01 (.09) -.02 (.07) 
-.04 (.09) 
-.03 (.09) 
-.07 (.06) 
-.06 (.07) 
 
 
.16 (.07) 
-.19 (.09) 
-.08 (.09) 
.06 (.06) 
-.00 (.07) 
-.00 (.07) -.00 (.06) .01 (.05) 
-.17 (.06) 
-.04 (.06) 
-.07 (.05) 
-.04 (.05) 
 
 
.08 (.05) 
.02 (.07) 
-.11 (.06) 
.05 (.04) 
-.12 (.05) 
.03 (.05) -.08 (.08) -.08 (.06) 
-.00 (.08) 
-.05 (.08) 
-.07 (.05) 
-.03 (.06) 
 
 
.09 (.06) 
-.08 (.08) 
-.05 (.08) 
-.02 (.06) 
-.15 (.06) 
.01 (.06) 
Anxiety .10 (.12) 
.29§ (.11) .25§ (.09) .28§ (.07) -.08 (.12) .15 (.09) .10 (.08) .15 (.06) .12 (.10) .12 (.07) 
Avoidant .06 (.11) .07 (.12) .03 (.08) .11 (.08) -.02 (.11) .01 (.10) -.05 (.08) -.00 (.07) -.08 (.10) .01 (.09) 
ADHD -.03 (.07) .11 (.07) -.12 (.05) 
.17§ (.05) .14 (.07) .19§ (.06) .04 (.05) .06 (.05) .06 (.06) .10 (.05) 
Antisocial .17 (.10) .08 (.11) .18 (.07) .04 (.08) .06 (.10) .00 (.09) .10 (.07) .11 (.07) .11 (.08) .13 (.08) 
 
          
Fathers           
Depressive -.11 (.10) -.06 (.10) -.08 (.07) .02 (.07) .06 (.10) -.02 (.08) -.02 (.07) -.01 (.06) .05 (.08) -.03 (.07) 
Anxiety 
.35§ (.12) .21 (.12) .18 (.09) .06 (.08) .05 (.12) -.01 (.10) .20 (.08) -.03 (.07) .16 (.10) .02 (.08) 
Avoidant -.03 (.11) .02 (.13) -.01 (.08) -.06 (.09) -.23 (.11) -.05 (.10) -.14 (.08) .04 (.07) -.19 (.09) -.05 (.09) 
ADHD .02 (.08) .01 (.09) .02 (.06) .06 (.06) .16 (.07) .07 (.07) .04 (.05) -.07 (.05) .00 (.06) .04 (.06) 
Antisocial -.00 (.07) -.07 (.09) -.08 (.07) -.01 (.06) .04 (.09) .06 (.07) .10 (.06) 
.21§ (.05) .14 (.08) .25§ (.06) 
Note: The child’s psychiatric symptom score at follow-up was predicted by the child’s psychiatric symptom score at baseline, the parental 
psychiatric symptoms at baseline (β12s) and the parental psychiatric symptoms at follow-up (β22s). The child’s psychiatric symptom score at 
baseline was also predicted by all parental psychiatric symptom scores at baseline (β11s). ADHD = attention deficit/hyperactivity disorders.  
 
§ p< 0.007.  
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Table S6. Means (SDs) of the Child’s Psychiatric Symptom Scores at Baseline and Follow-Up, Rated by Mothers (A) or by Fathers (B) for 
Children of Parents Whose Mother’s (A) or Father’s (B) Psychiatric Symptom Score was in the Normal or (Sub)Clinical Range at Baseline. 
 Parental score 
normal on all scales 
Parental score (sub)clinical at baseline 
Depressive Anxiety Avoidant  ADHD Antisocial 
A 
Mother 
Child baseline: 
 
N=460 
 
N= 95 
 
N = 43 
 
N = 42 
 
N = 91 
 
N = 54 
Depressive 5.02 (3.88) 7.72 (4.55)*** 7.98 (4.83)*** 8.24 (4.54)*** 7.25 (3.96)*** 8 (4.20)*** 
Anxiety  3.57 (2.76) 4.64 (2.82)*** 5.61 (2.74)*** 5.31 (3.01)*** 4.31 (2.84)* 4.54 (2.89)* 
ADHD 6.01(3.51) 7.24 (3.35)** 6.37 (3.70) 7.48 (3.62)* 7.71 (3.58)*** 7.33 (3.55)** 
ODD 3.54 (2.64) 4.54 (2.27)*** 4.33 (2.46) 4.60 (2.37)* 4.45 (2.55)** 4.74 (2.66)** 
Conduct 3.10 (3.27) 4.16 (4.06)** 4.14 (4.41) 4.12 (3.36) 4.43 (4.31)*** 4.67 (4.07)*** 
       
Child follow-up: N = 464 N = 93 N = 41 N = 43 N = 83 N = 44 
Depressive 3.07 (3.56) 4.82 (3.61)*** 4.78 (3.99)* 5.65 (3.92)*** 4.16 (3.87) 4.93 (3.96)* 
Anxiety 2.16 (2.44) 3.08 (2.70)** 3.78 (3.05)*** 3.93 (3.00)*** 2.57 (2.53) 3.02 (2.50) 
ADHD 4.73 (3.30) 5.57 (3.36) 4.59 (3.26) 5.93 (3.84) 6.17 (3.98)*** 5.43 (3.10) 
ODD 2.29 (2.28) 2.73 (1.98) 2.33 (1.97) 3.20 (2.29)* 2.64 (2.38) 3.02 (2.57) 
Conduct 1.99 (2.88) 2.15 (2.60) 1.98 (2.38) 2.56 (2.90) 2.99 (3.81)** 2.98 (2.94) 
       
B       
 
Father 
Child baseline: 
 
N = 348 
 
N=67 
 
N = 32 
 
N = 62 
 
N = 67 
 
N = 45 
Depressive 4.01 (3.711) 7.09 (4.21)*** 8.16 (4.10)*** 6.13 (4.09)*** 6.63 (4.18)*** 6.02 (3.67)*** 
Anxiety 2.87 (2.43) 4.25 (2.53)*** 5.06 (2.38)*** 4.31 (2.47)*** 4.46 (2.77)*** 3.98 (2.07)** 
ADHD 5.49 (3.26) 7.45 (3.15)*** 7.66 (2.54)*** 7.07 (3.35)*** 7.93 (2.85)*** 7.64 (2.96)*** 
ODD 3.03 (2.52) 4.24 (2.34)*** 4.38 (2.31)** 3.81 (2.13)* 4.19 (2.52)*** 4.89 (2.23)*** 
Conduct 2.80 (3.20) 4.28 (3.51)*** 3.81 (3.08)  3.84 (3.55)* 4.46 (3.60)*** 6.38 (4.54)*** 
       
Child follow-up: N = 275 N = 51 N = 25 N = 53 N = 51 N = 32 
Depressive 2.91 (3.57) 4.61 (3.54)*** 4.28 (3.41) 4.36 (3.75)** 4.20 (3.70)* 3.78 (2.34) 
Anxiety 1.95 (2.30) 2.71 (2.18) 2.88 (2.24) 2.71 (2.31) 2.88 (2.35)* 2.44 (1.97) 
ADHD 4.16 (3.21) 6.31 (3.14)*** 6.16 (2.98)* 5.57 (3.18)* 6.24 (3.39)*** 5.84 (2.84)* 
ODD 2.08 (2.16) 3.20 (2.19)** 3.24 (2.39) 2.77 (2.06) 2.98 (2.24) 3.59 (2.24)** 
Conduct 1.73 (2.54) 3.02 (3.08)** 2.58 (2.14) 2.09 (2.20) 2.16 (2.28) 3.56 (3.47)** 
Note: ADHD = attention deficit/hyperactivity disorder; ODD = oppositional defiant disorder. 
*p<.05; **p<.01; ***p<.001 
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Table S7. Means (SDs) of the Child’s Psychiatric Symptom Scores at Baseline and at Follow-Up for Children Whose Mother or Father Scored in 
the Normal Range or in the (Sub)Clinical Range on at Least One of the Syndrome Scales at Baseline.  
 
Mother’s psychiatric score 
 
Father’s psychiatric score 
 normal (sub)clinical  normal (sub)clinical  
 Baseline Follow-up d Baseline Follow-up d  Baseline Follow-up d Baseline Follow-up d  
Child score: N = 460 N = 464  N= 258 N = 248   N = 348 N = 275  N = 188 N = 138   
Depressive 5.02 (3.88) 3.07 (3.56) 0.52 7.00 (4.25) 4.21 (3.54) 0.71  4.02 
(3.71) 
2.91 (3.57) 0.30 6.16 (4.02) 3.62 (3.08) 0.71  
Anxiety 3.57 (2.76) 2.16 (2.44) 0.54 4.22 (2.84) 2.76 (2.52) 0.54  2.87 
(2.43) 
1.95 (2.30) 0.39 4.07 (2.63) 2.52 (2.22) 0.64  
ADHD 6.01(3.51) 4.73 (3.30) 0.38 7.38 (3.58) 5.65 (3.49) 0.49  5.49 
(3.26) 
4.16 (3.21) 0.34 7.19 (3.32) 5.67 (3.33) 0.46  
ODD 3.54 (2.64) 2.29 (2.28) 0.51 4.52 (2.56) 2.73 (2.30) 0.74  3.03 
(2.52) 
2.08 (2.16) 0.41 4.30 (2.42) 3.07 (2.35) 0.52  
Conduct 3.10 (3.27) 1.99 (2.88) 0.36 4.33 (4.14) 2.59 (3.29) 0.47  2.80 
(3.20) 
1.73 (2.54) 0.37 4.41 (3.80) 2.69 (2.96) 0.50  
Note: The effect size (d) for the mean difference at baseline and follow-up is given by whether the parents scored in the normal or (sub)clinical 
range. ADHD = attention-deficit/hyperactivity disorder; ODD = oppositional defiant disorder  
 
 
